XRCC1 and non-small cell lung carcinoma: A more recent meta-analysis including 23 studies (n = 5567) of Asian patients with non-small-cell lung cancer, showed that rs25487 variant of the XRCC1 gene is a potential marker to predict clinical outcomes of platinum-based chemotherapy in Asian patients [11].